Literature DB >> 33617174

Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study.

Brian J Boyarsky1, Michael T Ou1, William A Werbel2, Robin K Avery2, William A Clarke3, Aaron A R Tobian3, Allan B Massie1, Dorry L Segev1, Jacqueline M Garonzik Wang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33617174      PMCID： PMC8085060          DOI： 10.1097/TP.0000000000003637

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   5.385


× No keyword cloud information.
  4 in total

1.  Convalescent Plasma to Treat COVID-19: Possibilities and Challenges.

Authors:  John D Roback; Jeannette Guarner
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

2.  Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.

Authors:  Manish M Patel; Natalie J Thornburg; William B Stubblefield; H Keipp Talbot; Melissa M Coughlin; Leora R Feldstein; Wesley H Self
Journal:  JAMA       Date:  2020-11-03       Impact factor: 56.272

3.  Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.

Authors:  Sabra L Klein; Andrew Pekosz; Han-Sol Park; Rebecca L Ursin; Janna R Shapiro; Sarah E Benner; Kirsten Littlefield; Swetha Kumar; Harnish Mukesh Naik; Michael J Betenbaugh; Ruchee Shrestha; Annie A Wu; Robert M Hughes; Imani Burgess; Patricio Caturegli; Oliver Laeyendecker; Thomas C Quinn; David Sullivan; Shmuel Shoham; Andrew D Redd; Evan M Bloch; Arturo Casadevall; Aaron Ar Tobian
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

4.  SARS-CoV-2 viral dynamics in immunocompromised patients.

Authors:  Sophie Caillard; Ilies Benotmane; Gabriela Gautier Vargas; Peggy Perrin; Samira Fafi-Kremer
Journal:  Am J Transplant       Date:  2020-10-31       Impact factor: 8.086
  4 in total
  7 in total

1.  Lack of immune response after mRNA vaccination to SARS-CoV-2 in a solid organ transplant patient.

Authors:  Debra S Rusk; Christian C Strachan; Benton R Hunter
Journal:  J Med Virol       Date:  2021-05-03       Impact factor: 20.693

2.  Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept.

Authors:  Michael T Ou; Brian J Boyarsky; Teresa P Y Chiang; Sunjae Bae; William A Werbel; Robin K Avery; Aaron A R Tobian; Allan B Massie; Dorry L Segev; Jacqueline M Garonzik-Wang
Journal:  Transplantation       Date:  2021-09-01       Impact factor: 5.385

3.  Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.

Authors:  Anna Mrzljak; Željka Jureković; Jadranka Pavičić-Šarić; Vladimir Stevanović; Irena Tabain; Željka Hruškar; Danko Mikulić; Ljubo Barbić; Tatjana Vilibić-Čavlek
Journal:  Biochem Med (Zagreb)       Date:  2021-10-15       Impact factor: 2.313

4.  COVID-19 in Recent Lung Transplant Recipients: Clinical Outcomes and Management Strategies.

Authors:  Julia Zimmermann; Olaf M Glueck; Jan M Fertmann; Wulf G Sienel; Gökce Yavuz; Fuad Damirov; Julia R Kovács; Amanda Tufman; Michael Irlbeck; Nikolaus Kneidinger; Sebastian Michel; Teresa Kauke; Rudolf A Hatz; Christian P Schneider
Journal:  Transplant Proc       Date:  2022-01-10       Impact factor: 1.014

Review 5.  COVID-19 and kidney disease: insights from epidemiology to inform clinical practice.

Authors:  Viyaasan Mahalingasivam; Guobin Su; Masao Iwagami; Mogamat Razeen Davids; James B Wetmore; Dorothea Nitsch
Journal:  Nat Rev Nephrol       Date:  2022-04-13       Impact factor: 42.439

Review 6.  Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients.

Authors:  Varun K Phadke; Nicholas Scanlon; Stanley C Jordan; Nadine G Rouphael
Journal:  Curr Transplant Rep       Date:  2021-03-04

7.  Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.

Authors:  Isabel Campos-Varela; Oscar Len; Ares Villagrasa; Ester Márquez-Algaba; Juliana Esperalba; Cristina Dopazo; Ibai Los-Arcos; Andrés Antón; Lluís Castells
Journal:  Transpl Int       Date:  2021-07-27       Impact factor: 3.842
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.